Viewpoints

Polling Change

June 04, 2024

The political landscapes of both the EU and UK are set to change after the latest elections, which could affect the bio/pharma industry.

Royal Recognition

May 03, 2024

Pharmaceutical company, Nanomerics, and several companies that work with the pharmaceutical industry have been recognized by King Charles III for business achievements.

Tapping into the Potential of Biologics

May 03, 2024

Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.

Streamlining Variations

April 02, 2024

A revised regulatory variation framework should make lifecycle management more efficient in Europe.

Budget Benefit

March 02, 2024

Wider life sciences industries in the UK and Europe are receiving favourable financial support from governing bodies.

On the Up and Up

February 02, 2024

The industry’s M&A activity is on the up and expected to continue to rise in 2024.

Unlucky for Some

January 02, 2024

Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.

Falling Short

December 02, 2023

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.

CPHI Annual Report: VC Capital Investment and Contract Services Growth in 2024

October 24, 2023

The report indicates a rise in biotech funding and subsequent growth for pharma contract services.

Booster Shot for Pharma

September 02, 2023

European vaccine manufacturing is being boosted with high level investments.